Normal precursor B cells and lymphoblasts of precursor B-ALL may be hard to distinguish. How is an immunofluorescence test for TdT that can differentiate hematogones from leukemic blasts applied? American Journal of Clinical Pathology
Oncology nurse specialists provide care, support, and information to breast cancer patients, but thus far, evidence is limited about their individual impact on certain aspects of quality of life. Medscape Medical News
Dr. Maurie Markman describes the somewhat controversial work of investigators who explored the relative role of chemotherapy vs. pelvic radiation in intermediate- or high-risk endometrial cancer. Medscape Hematology-Oncology
Acute myeloid leukemia is a challenging disease to treat, but new molecular and cytogenetic markers can help clinicians guide patients to more effective and safe therapy. The current article reviews these markers and offers strategies for their clinical application. Journal of the National Comprehensive Cancer Network
